Amova Asset Management Americas, Inc.
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1480751
NEW YORK, NY
Position in NTLA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$49,026,190
+$23,731,548 QoQ
Shares Held
2,897,529
+46.9% QoQ
Ownership
2.07%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#14
of 327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amova Asset Management Americas, Inc. holds $354,236,903 across 20 Biotechnology names. NTLA ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
1,720,097 | $93,814,090 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
This page
|
2,897,529 | $49,026,190 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
983,462 | $23,858,788 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
5,511,687 | $20,227,891 | |
| 6 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
1,960,458 | $13,174,277 | |
| 7 | ABSI |
Absci Corp
|
1,013,965 | $11,751,854 | |
| 8 | PRME |
Prime Medicine, Inc.
|
2,407,018 | $8,881,896 |
All Filings in NTLA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,026,190 | 2,897,529 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $25,294,642 | 1,973,061 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $19,710,224 | 2,192,461 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $40,668,363 | 2,354,856 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,056,465 | 2,671,265 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $20,088,316 | 2,825,361 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $34,894,450 | 2,992,663 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $64,699,558 | 3,148,397 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $72,907,079 | 3,257,689 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $93,515,238 | 3,399,318 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $106,061,355 | 3,478,562 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $111,311,727 | 3,520,295 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $138,434,071 | 3,394,656 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $116,020,168 | 3,112,964 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $103,832,709 | 2,976,002 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $165,861,410 | 2,963,928 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $143,951,599 | 2,781,136 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $208,727,788 | 2,872,269 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $325,621,490 | 2,753,903 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $321,951,011 | 2,399,933 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $496,003,027 | 3,063,449 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $388,696,633 | 4,843,270 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $277,677,292 | 5,104,362 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $120,522,818 | 6,062,516 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $129,978,157 | 6,183,547 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $86,726,146 | 7,091,263 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||